Our products comply with the (FFD&CA) Federal Food, Drug, & Cosmetics Act of 1938, and as enacted by the 75th United States Congress. The act is intended to protect consumers against fraudulent claims, mis-labeling, mis-branding, poor manufacturing practices and retail sales of products that violate the FDA rules, and regulations that are supported with statutes, and evidence-based science.
All of Guardian recreational cannabis dispensary products are also complaint with the US farm Bill of 2018, which permits the cultivation, processing, manufacturing, and retail sales of cannabis Hemp products that do not contain more than 0.03% D-9 (THC) at a dry weight, and all of our products are sourced 100% from US Cultivated Colorado Organic Cannabis Sativa L, not a synthetic source. All products in this retail store meet, and exceed the requirements of the FDA, and do not violate any state of Federal laws.
All of our products are third-party tested for quality, compliance, and contain ZERO toxins, Heavy-Metals, Aluminum, Copper, Zinc, or other harmful made made, synthetic substances that are not intended for consumption to human and animal life. Our products are free of pesticides, insecticides, and poisons. Our products do not treat, we do not diagnose, we're not a medical facility. We're not licensed to medically consult people, and do not practice any recommendations for human or animal health or wellness.
Third Party Testing has been something that companies have been posting for a few years now, but at the retail level, we should not be releasing such testing. Why? Because most every customer that walks into the store does not even understand the testing, and they would not be able to decipher the analytical results.
Third- Party Testing has always been something companies have conducted. This information is most historically utilized or B2B and manufacturing and wholesale relationships. Releasing third-party analytical testing to the general public poises a security risk to the company, and subjects the retailer to fraud, and theft. Therefor we DO NOT share results with the general public, but will release testing to authorities, state agencies, and anyone with a "Right to know" of if it would produce a positive outcome for a particular situation that warranted releasing analytical testing to any third-party.
The Agriculture Improvement Act of 2018, Public Law 115-334 (the AIA), was signed into law on December 20, 2018. It provided a new statutory definition of (CANNABIS SATIVA L.) “hemp” and amended the definition of marihuana under 21 U.S.C. 802(16) and the listing of tetrahydrocannabinols under 21 U.S.C. 812(c).
The AIA thereby amends the regulatory controls over marihuana, tetrahydrocannabinols, and other marihuana-related constituents in the Controlled Substances Act (CSA). This rule making makes four conforming changes to DEA's existing regulations:
It modifies 21 CFR 1308.11(d)(31) by adding language stating that the definition of “Tetrahydrocannabinols” does not include “any material, compound, mixture, or preparation that falls within the definition of hemp set forth in 7 U.S.C. 1639 o.”
It removes from control in schedule V under 21 CFR 1308.15(f) a “drug product in finished dosage formulation that has been approved by the U.S. Food and Drug Administration that contains cannabidiol (2-[1R-3-methyl-6R-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol) derived from cannabis and no more than 0.1% (w/w) residual tetrahydrocannabinols.”
It also removes the import and export controls described in 21 CFR 1312.30(b) over those same substances. It modifies 21 CFR 1308.11(d)(58) by stating that the definition of “Marihuana Extract” is limited to extracts “containing greater than 0.3 percent delta-9-tetrahydrocannabinol on a dry weight basis.”
This retail store operates under the explicit oversight of the F.D.A., Food and drug administration, as outlined in the US Farm Bill signed into law by Congress on December 20th, 2018.
Our products do not violate (Any-section) of TITLE 21 of the United States Code 301, Titled the US Cosmetics Act of 1938. Our products do NOT violate any of the (F.F.D,&C.A.) Federal Food, Drug, and Cosmetics Act amended April 23rd, 2021, and our products are compliant, and not in violation of any of the following codes;
Our retail store operates legally, and does not violate any of Kansas Statutes regarding hemp cultivation, processing, manufacturing and retail distribution. We operate under explicit oversight of the FDA & DEA and only require licensing in Kansas if Guardian MMJ recreational cannabis dispensary votes to participate in the commercial Hemp program so that we can cultivate, produce and process Kansas Grown Hemp, which we would process for locally cultivated Kansas products. This process of oversight is enacted due to US Federal Efforts passed into law through the FDA, and the US farm Bill of 2018. Kansas either has or required to submit a plan to the US Department of Agriculture, regarding a plan to oversee, regulate and implement the commercial Hemp program in Kansas, as outlined by US Federal Law. FDA, and KDHE mission is to protect consumers health and safety, and we at Guardian MMJ, DO NOT NEED to be TOLD TWICE to follow this law, set of rules or regulations that are intended to protect all consumers from fraudulent medical claims, fraudulent manufacturing, fraudulent labeling or any other act that could potentially harm a consumer. Guardian MMJ, has our own set of rules when it comes to compliance, and those rules are pulled straight from the FDA Statutes, Regulations through the cosmetics act, and from the US farm bill of 2018. We look forward to expanding our retail operations to possible commercial participation in the Hemp cultivation and processing program, for the purpose of obtaining our own organic, locally cultivated Hemp, so we can manufacture legal Hemp products compliant with GMP, US Farm Bill, and US Cosmetics Act.